Skip to main content
. 2017 Mar 31;18(4):743. doi: 10.3390/ijms18040743

Table 2.

Proportion of elevated ECT2 and CEA detected in serum in different combination of patients with colorectal cancer.

CEA/ECT Expression Stage I and II, n = 17 (%) Stage III, n = 30 (%) Stage IV, n = 43 (%) All, n = 90 (%)
CEA+ECT2 4 (24) 9 (30) 9 (21) 22 (24)
CEAECT2+ 9 (53) 11 (37) 10 (23) 30 (33)
CEA+ECT2+ 1 (6) 6 (20) 6 (20) 24 (27)
CEA+ and/or ECT2+ 14 (82) 26 (87) 26 (84) 76 (84)
CEAECT2 3 (18) 4 (13) 7 (16) 14 (16)

Cut-off level for CEA is 5 ng/mL and for ECT2 is 1.79 ng/mL.